Sero-response rates for placebo , BRV-TV dose-levels @ ( @ ) FFU , @ ( @ ) FFU , @ ( @ ) FFU , and Rotateq at @ days post third dose were @ % , @ % , @ % , @ % , and @ % respectively using the four-fold or more criteria .